Welcome to our dedicated page for Global Medical SEC filings (Ticker: GMRE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Global Medical REIT Inc. (GMRE) SEC filings page provides direct access to the company’s regulatory disclosures, along with AI-assisted summaries to help interpret complex documents. As a net-lease medical real estate investment trust, GMRE files annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K that describe its healthcare real estate portfolio, lease structures, financing arrangements and governance matters.
In these filings, Global Medical REIT details its rental revenue, net income or loss, Funds From Operations (FFO), Adjusted Funds From Operations (AFFO), Funds Available for Distribution (FAD), Earnings Before Interest, Taxes, Depreciation and Amortization for Real Estate (EBITDAre and Adjusted EBITDAre), Net Operating Income (NOI), cash NOI and same-store cash NOI. The company also discloses portfolio occupancy, leasable square footage, annualized base rent, lease expiration schedules and the mix of outpatient medical buildings, inpatient rehabilitation facilities, hospitals and other medical real estate. Our AI tools highlight how these metrics are calculated and what they imply for operating performance and leverage.
Recent Form 8-K filings for GMRE include disclosures about amendments and restatements of its credit facility, including extended maturities for its revolver and term loans and the removal of a SOFR credit spread adjustment, as well as the use of forward-starting interest rate swaps to hedge term loan exposure. Other 8-Ks describe the authorization and mechanics of a one-for-five reverse stock split, the approval of a common stock repurchase program, the appointment of a new Chief Executive Officer and President, and the planned retirement of a long-serving independent director.
Filings also cover capital markets transactions such as the underwriting agreement for GMRE’s 8.00% Series B Cumulative Redeemable Preferred Stock and related Articles Supplementary and partnership agreement amendments. Through this page, users can review Forms 3, 4 and 5 for insider ownership and trading activity, as well as proxy materials that discuss executive compensation and board structure when available. Real-time updates from the SEC’s EDGAR system, combined with AI-generated explanations, make it easier to understand how Global Medical REIT’s filings relate to its portfolio strategy, capital structure and dividend practices.
Chiron Real Estate Inc. entered into a Master Note and Guaranty Agreement with NYL Investors LLC and certain affiliates, creating an uncommitted senior note facility for its operating partnership. The facility permits issuance of senior unsecured notes in one or more series with an aggregate outstanding principal of up to
Notes may be issued for up to three years from the agreement’s effective date, subject to earlier termination events, and each series will mature within ten years of issuance. Each issuance must be at least
Chiron Real Estate Inc., formerly Global Medical REIT, is an internally managed healthcare REIT focused on physician group and health-system facilities. As of December 31, 2025, it owned 189 buildings with about 5.1 million leasable square feet and annualized base rent of roughly
Total gross real estate investments were about
Chiron Real Estate Inc. reported that General Counsel and Secretary Jamie Allen Barber received equity-based awards in the form of LTIP Units in Chiron Real Estate LP, the company’s operating partnership. On February 24, 2026, Barber acquired 5,539 LTIP Units and an additional 2,025 LTIP Units at a price of $0.00 per unit as grant or award acquisitions.
According to the disclosures, one set of LTIP Units is scheduled to vest on February 24, 2029, subject to continued employment, while another grant had 50% of its LTIP Units become vested and nonforfeitable on February 24, 2026 after meeting market-based performance criteria, with the remaining 50% vesting on February 24, 2027. Vested LTIP Units that reach capital account parity may be exchanged for cash or, at the issuer’s election, for common stock on a one-for-one basis. The filing notes that all amounts reflect a 1-for-5 reverse stock split effective September 19, 2025.
KIERNAN ROBERT J reported acquisition or exercise transactions in this Form 4 filing.
Chiron Real Estate Inc. reported that its CFO and Treasurer, Robert J. Kiernan, received equity incentive awards in the form of LTIP Units in Chiron Real Estate LP, the company’s operating partnership. On February 24, 2026, he was granted 10,385 and 3,492 LTIP Units at a grant price of $0.00 per unit under the 2016 Equity Incentive Plan.
According to the award terms, all of these LTIP Units are scheduled to vest on February 24, 2029, if he remains employed through that date. Once vested and after achieving capital account parity under the partnership agreement, the LTIP Units may be exchanged for cash or, at the issuer’s election, for common stock on a one-for-one basis. The amounts shown already reflect the company’s prior 1‑for‑5 reverse stock split.
Chiron Real Estate Inc. reported that COO Holley Danica acquired LTIP Units in the company’s operating partnership through equity awards. On February 24, 2026, she received grants of 5,816 and 2,270 LTIP Units at a price of
According to the accompanying descriptions, certain LTIP Units vest based on continued employment and market-based performance, with 50% vested and nonforfeitable as of
Chiron Real Estate Inc. reported that CIO Leon Alfonzo acquired two awards of LTIP Units (rights to buy) in Chiron Real Estate LP, totaling 10,385 and 3,273 units, at a stated price of
The LTIP Units are equity incentives under the 2016 Equity Incentive Plan and have no expiration date. All LTIP Units in one grant vest on
Chiron Real Estate Inc. director and CEO/President Mark Okey Decker Jr reported equity compensation awards in the form of LTIP Units in Chiron Real Estate LP, the company’s operating partnership. He acquired 16,616 LTIP Units and 4,702 LTIP Units, both at a stated price of $0.00 per unit.
According to the award terms, some LTIP Units vest fully on February 24, 2029 subject to continued employment, while another grant vests 50% on February 24, 2026 based on market-based performance criteria as of December 31, 2025 and February 24, 2026, and 50% on February 24, 2027. Once vested and after achieving capital account parity, these LTIP Units may be exchanged for cash or, at the company’s election, for common stock on a one-for-one basis and have no expiration date.
Chiron Real Estate Inc., formerly Global Medical REIT, reported 2025 results, updated its capital strategy and completed a corporate rebrand. For 2025, total revenue was $148.2 million and the company recorded a net loss of $6.9 million, driven in part by $13.0 million of property impairments.
FFO attributable to common stockholders and noncontrolling interest was $57.6 million ($3.97 per share and unit), while Core FFO reached $65.8 million ($4.53 per share and unit). Leverage was 44.4% at December 31, 2025, with $653.9 million of consolidated debt at a 3.74% weighted average interest rate and no maturities in 2026 or 2027.
The board kept the annualized common dividend at $3.00 per share but shifted to monthly payments, declaring $0.25 per share for each of April, May and June 2026. The company invested $7.1 million for a 49% interest in an active adult joint venture and set 2026 Core FFO guidance at $4.30 to $4.45 per share and unit. A key tenant, White Rock Medical Center, filed for Chapter 11, and Chiron carried a $1.4 million net receivable from its support efforts.
Global Medical REIT Inc. reported that director Henry Cole has informed the Board that he intends to step down as a director, effective at the Company’s 2026 Annual Meeting of Stockholders. He will not be nominated for re-election, and his service will end when his current term expires on the date of that meeting.
The Company states that Mr. Cole’s decision to step down is not due to any disagreement with Global Medical REIT Inc. on matters related to its operations, policies, or practices, indicating an orderly and planned board transition rather than a dispute-driven change.
Global Medical REIT Inc. disclosed an insider share purchase by its CEO and President. On 12/05/2025, the reporting person, who also serves as a director, bought 10,000 shares of common stock at a price of $32.51 per share. Following this transaction, the individual directly owned 54,774 shares of Global Medical REIT common stock and indirectly owned 3,404 additional shares through a spouse.